News
11-20-2019, 05:10 AM
The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test.
More... (https://www.news-medical.net/news/20191120/Study-shows-gender-differences-in-prognosis-predictive-utility-of-breast-cancer-recurrence-score.aspx)
More... (https://www.news-medical.net/news/20191120/Study-shows-gender-differences-in-prognosis-predictive-utility-of-breast-cancer-recurrence-score.aspx)